Company: IMNN
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022120
Chunk: 50

Company: Imunon, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 8
Chunk 50
---
 Executive Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

    31.2+
    Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

    32.1*
    Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

    101**
    The
    following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 formatted in
    XBRL (Extensible Business Reporting Language): (i) the unaudited Consolidated Balance Sheets, (ii) the unaudited Consolidated Statements
    of Operations, (iii) the unaudited Consolidated Statements of Comprehensive Loss, (iv) the unaudited Consolidated Statements of Cash
    Flows, (v) the unaudited Consolidated Statements of Change in Stockholders’ Equity (Deficit), and (vi) Notes to Consolidated
    Financial Statements.

    +
    Filed
    herewith.

    *
    Exhibit
    32.1 is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act
    of 1934, as amended, or otherwise subject to the liability of that section, nor shall such exhibit be deemed to be incorporated by
    reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Securities Exchange
    Act, except as otherwise stated in such filing.

    **
    XBRL
    information is filed herewith.

    104
    Cover
    Page Interactive Data File (embedded within the Inline XBRL document)

34

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.

    November
    13, 2025
    IMUNON,
    INC.

    Registrant

    By:
    /s/
    Stacy R. Lindborg Ph.D.

    Stacy
    R. Lindborg, Ph.D.